FDA NDC Directory · JSON-LD · Markdown

Tarpeyo

NDC 81749-004 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic namebudesonide
Labeler / ManufacturerCalliditas Therapeutics AB
Marketing categoryNew Drug Application (innovator) · App NDA215935
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsBUDESONIDE (4 mg/1)
Marketing started20211215
Package count1

External sources

Source: openFDA. Public-domain (CC0).